Short answer
NEOGENOMICS INC (NEO) filed an 8-K current report with the SEC on June 17, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 8.01 (Other Events). NeoGenomics priced convertible senior notes due 2032 in a Rule 144A offering to qualified institutional buyers.
NEOGENOMICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- NeoGenomics priced convertible senior notes due 2032 in a Rule 144A offering to qualified institutional buyers
- Convertible debt issuance creates potential future equity dilution while extending financing maturity to 2032
- Offering terms, including principal amount, coupon and conversion terms, are contained in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- $275M convertible notes due 2032 priced at 0.75%, with potential additional issuance of $41.25M
- Net proceeds of approximately $266.15M directed toward retiring $276M existing notes and funding capped calls
- Initial conversion price approximately $14.16, a 35% premium to $10.49 share price, limiting near-term dilution
- $25M potential share repurchase supports per-share value but uses proceeds that could otherwise fund operations
- Capped calls priced at $20.98 aim to offset dilution, while dealer hedging may increase share-price volatility
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NEOGENOMICS INC 8-K filings
Get the next NEO 8-K as it lands
Follow NEO for push alerts, or ask the research agent what this filing means.